ARVN
Arvinas, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -9.1% ·
flujo de acciones +5.2% ·
nuevas posiciones netas -10.0%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | -2 | 34.83M | $289.66M | +6 | −8 |
| Q1 2026 | 87 | +4 | 31.95M | $338.79M | +7 | −3 |
| Q4 2025 | 83 | +1 | 38.40M | $455.50M | +2 | −1 |
| Q3 2025 | 15 | 0 | 28.59M | $243.63M | — | −1 |
| Q2 2025 | 13 | -1 | 30.77M | $226.45M | +1 | −2 |
| Q1 2025 | 11 | +1 | 13.86M | $97.33M | +1 | — |
| Q4 2024 | 10 | -1 | 12.65M | $242.44M | — | −1 |
| Q3 2024 | 10 | 0 | 10.38M | $255.76M | — | — |
| Q2 2024 | 10 | — | 10.17M | $270.82M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 4.10M | +6.5% | $78.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 4.10M | +6.5% | $78.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 3.07M | +13.5% | $58.90M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 3.07M | +13.5% | $58.90M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (pasivo) | 1.64M | — | $31.38M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 1.51M | -0.6% | $28.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 1.51M | -0.6% | $28.97M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 1.24M | -6.0% | $23.84M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 397.50K | +2.9% | $7.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Millennium Management ✦ | 314.84K | +50.9% | $6.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Marshall Wace ✦ | 268.03K | +57.3% | $5.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 268.03K | +57.3% | $5.14M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 68.90K | -52.3% | $1.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 29.74K | -9.3% | $570,039 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 29.74K | -9.3% | $570,039 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 29.74K | -9.3% | $570,039 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 29.74K | -9.3% | $570,039 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| D. E. Shaw & Co. | $914,364 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 205 tenedores, 53.97M acciones, $548.70M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.